General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0ASPMX
ADC Name
Immunoconjugate (Bayer AG)
Organization
Bayer AG
Drug Status
Terminated in phase 1
Indication
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Terminated in phase 1
Antibody Name
Undisclosed
Antigen Name
Mesothelin (MSLN)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.